Discovery uncovers possible new mechanism behind retinal ailment that affects millions
New research from scientists at the University of Maryland School of Medicine (UM SOM) has found that tiny lumps of calcium phosphate may be an important triggering factor for age-related macular degeneration (AMD), a degenerative eye disease that can cause severe vision loss and blindness.
This is the first time these mineral deposits have been implicated in the disease, which affects more than 10 million Americans. The article appeared in the latest issue of the Proceedings of the National Academy of Sciences.
Biochemist Richard Thompson, PhD, along with his colleague from University College, London, Imre Lengyel, PhD, and a multidisciplinary international team studied retinal samples from a group of elderly patients, some of whom had AMD.
They found that the AMD samples contained tiny spherules of a mineralized calcium phosphate known as hydroxyapatite, or HAP. HAP is common in the body - it comprises the hard part of bones and teeth - but it had never been identified in that part of the eye before.
AMD develops slowly over decades, with the buildup of fatty protein deposits in the retina, which cause damage by blocking the flow of nutrients into the light-sensitive portion of the eye, and of waste products out. Scientists have known about these deposits for over a century, but their origins remained a mystery.
Thompson and Lengyel discovered that the deposits appear to form around the tiny bits of HAP. Once these chunks appear, the fatty protein material coalesces around it; over years, these globules build up.
They discovered the possible role of HAP by examining tissue samples from patients using X-ray diffraction and fluorescent staining chemicals. "We had no idea that HAP might be involved," says Prof. Thompson, who is an associate professor of biochemistry and molecular biology at the school. "That's what makes this work so exciting. It opens up a lot of new research opportunities."
AMD gets its name because it affects the macula, the central area of the retina. The macula is responsible for the sharp, direct vision required for reading and driving.. The disease tends to strike older people - more than 11 percent of Americans over the age of 80 have AMD, and the risk of getting advanced AMD is nearly 30 percent for those over the age of 75. Other risk factors include smoking, some chronic infections, and chronic inflammatory diseases such as diabetes.
Thompson and Lengyel are looking into the possibility of using the presence of HAP as an early warning signal for AMD risk with a hope that this will aid early intervention before patients have suffered irreversible vision loss. Eventually, they say, it may be possible to devise methods to reduce HAP deposits or limit the growth and progression of the disease. "We think HAP plays a key role in this process," said Lengyel. "This is a new explanation for how these deposits start."
AMD is the most common cause of blindness in older people in developed countries, affecting tens of millions worldwide. The disease causes the breakdown of the macula, the portion of the retina which provides the highest resolution vision, used in such activities as reading or driving a car. There is no cure; sometimes damage can be slowed or halted by injections of medicines that stop the growth of the deposits. The cost of AMD is estimated at more than $340 billion.
"This work epitomizes the school's mission," said Dean E. Albert Reece, MD, PhD, MBA, who is vice president for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the School of Medicine. "Dr. Thompson and his colleagues have provided new insight into the deep mechanisms of this terrible disease, and in doing so, they have created new avenues of research that have the potential to help millions of people."
The work was supported in part by the Bright Focus Foundation in the USA and the Bill Brown Charitable Trust in the UK.
Scientists from several institutions made key contributions to the study and are also co-authors, including Drs. Jacob G. Bundy, Emrys A. Jones, David S. McPhail, and Sarah Fearn (Imperial College London, UK); Elöd Körtvély, Karsten Boldt, and Marius Ueffing (Universitatsklinikum, Tübingen, Germany); Jane M. Flinn (George Mason University, Fairfax, VA); Antonio Lanzirotti (The University of Chicago, IL); and Valentia Reffatto, Savanjeet Guy Singh Ratu, Laurenz Pauleikhoff, and Alan C. Bird (University College London, UK). Funding and support was also provided by the Moorfields Eye Hospital Special Trustees, the Mercer Fund from Fight for Sight, the Engineering and Physical Sciences and Natural Environment Research Councils, in the UK, and the US Department of Energy, Office of Science.
About the University of Maryland School of Medicine
The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland's Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world.
David Kohn | EurekAlert!
First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf
Do microplastics harbour additional risks by colonization with harmful bacteria?
05.04.2018 | Leibniz-Institut für Ostseeforschung Warnemünde
At the Hannover Messe 2018, the Bundesanstalt für Materialforschung und-prüfung (BAM) will show how, in the future, astronauts could produce their own tools or spare parts in zero gravity using 3D printing. This will reduce, weight and transport costs for space missions. Visitors can experience the innovative additive manufacturing process live at the fair.
Powder-based additive manufacturing in zero gravity is the name of the project in which a component is produced by applying metallic powder layers and then...
Physicists at the Laboratory for Attosecond Physics, which is jointly run by Ludwig-Maximilians-Universität and the Max Planck Institute of Quantum Optics, have developed a high-power laser system that generates ultrashort pulses of light covering a large share of the mid-infrared spectrum. The researchers envisage a wide range of applications for the technology – in the early diagnosis of cancer, for instance.
Molecules are the building blocks of life. Like all other organisms, we are made of them. They control our biorhythm, and they can also reflect our state of...
University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.
Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.
Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.
Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...
Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.
The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...
13.04.2018 | Event News
12.04.2018 | Event News
09.04.2018 | Event News
25.04.2018 | Physics and Astronomy
25.04.2018 | Materials Sciences
25.04.2018 | Studies and Analyses